Patient Registry Software Market Set for Steady Growth to US$ yy Million by 2031, Led by North America's 44% Market Share

The Global Patient Registry Software Market size was valued at US$ yy million in 2023 and is estimated to reach US$ yy million by 2031, growing at a CAGR of 9.2% during the forecast period (2024-2031).

This market is expanding due to the rising demand for real-world evidence in clinical research, regulatory compliance, and personalized medicine initiatives worldwide. Healthcare providers and pharmaceutical companies increasingly rely on these software solutions to track patient outcomes for chronic diseases like cancer, diabetes, and rare disorders, improving data interoperability with EHR systems. Cloud-based deployments are accelerating adoption, especially in profit-oriented sectors like pharma and hospitals, amid a shift to value-based care models.

Request Executive Sample Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/patient-registry-software-market?ram

Key Industry Developments

United States:
✅ February 2026: Oracle launched advanced cloud-based patient registry enhancements with AI-driven analytics for real-time population health insights, improving data interoperability and predictive modeling for chronic disease management in U.S. hospitals.

✅ December 2025: MEDITECH released an upgraded Expanse Patient Registry platform integrating generative AI for streamlined clinical research and outcome tracking, boosting efficiency in U.S. healthcare systems.

✅ October 2025: IQVIA introduced a next-gen RWD-powered registry software module focused on precision medicine trials, enabling faster U.S. FDA submissions through enhanced real-world evidence generation.​

Japan:
✅ January 2026: Fujitsu unveiled a blockchain-secured patient registry solution tailored for Japan's national health database, advancing secure data sharing for rare disease research and telemedicine applications.

✅ November 2025: NEC Corporation announced R&D breakthrough in AI-optimized registry software for Japan's aging population, featuring automated compliance with JMDN regulations and predictive analytics for long-term care registries.

✅ October 2025: Omron Healthcare debuted a cloud-native patient registry app with wearable integration for cardiovascular monitoring, supporting Japan's precision health initiatives through real-time data aggregation.
​
Strategic Acquisitions and Partnerships
✅ Registry Partners launched RegiHealth in May 2025, a program to optimize healthcare registries and maximize returns on patient registry investments for hospitals and systems.

✅ Medalogix merged with Forcura to form a $1B healthcare software entity, enhancing capabilities in home healthcare, hospice, and patient data management sectors.​

✅ Waystar acquired Iodine Software to integrate AI for revolutionizing healthcare payments, reducing denials and supporting registry-related workflows in patient data handling.​

Key Players:
Dacima Software Inc. | McKesson Corporation | Global Vision Technologies Inc. | ImageTrend Inc. | Liaison Technologies | Optum Inc. | Phytel Inc. | Quintiles IMS Holdings Inc.

Strategic Leadership Analysis: Top 5 Players in Patient Registry Software Market 2026
-Dacima Software Inc.: Launched Dacima Registry platform with advanced flexible data capture capabilities, enabling no-code database design for patient registries, sophisticated edit checks, and dynamic form activation to streamline health research data collection.

-ImageTrend Inc.: Advanced the ImageTrend Patient Registry with integrated analytics and real-time data visualization features, enhancing interoperability for EMS and public health registries to support population health management and outcomes tracking.

-McKesson Corporation: Strengthened its patient registry solutions within the McKesson Health Record platform, introducing AI-driven data aggregation and compliance tools for oncology and chronic disease registries to improve care coordination.

-Optum Inc.: Expanded Optum's population health management suite with registry modules featuring predictive analytics and FHIR interoperability, enabling proactive patient engagement and value-based care through seamless EHR integration.

-IQVIA (formerly Quintiles IMS Holdings Inc.): Deployed IQVIA's Core Registry platform with AI-powered real-world evidence generation, incorporating advanced pharmacovigilance and decentralized trial features to accelerate insights from global patient data networks.

Purchase Corporate License | Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=patient-registry-software-market?ram

Main Drivers and Trends Shaping the Future of Patient Registry Software
-Real-World Evidence Demand: Growing need for RWE in drug development, regulatory approvals, and value-based care drives adoption of registries for longitudinal data on chronic and rare diseases.

-EHR Integration and Interoperability: Rising EHR adoption enables seamless data access across systems, supporting multi-site registries and population health management.

-AI and Analytics Advancements: Integration of AI, machine learning, and predictive tools unlocks insights from registry data for personalized medicine and clinical decision-making.

-Regulatory and Chronic Disease Pressures: Government mandates for data standardization, plus the burden of chronic conditions, fuel specialized disease registries and cloud-based scalability.

-Market Hurdles: Data privacy concerns, interoperability challenges, high implementation costs, and skilled resource shortages constrain growth despite strong demand.

Regional Insights:
-North America: 44% (Largest share, driven by advanced healthcare infrastructure and high adoption of software technologies).​

-Asia Pacific: 30% (Fastest growing, fueled by digital health initiatives and urbanization in China and India).​

-Europe: 20% (Supported by national registry programs and predictive analytics investments).​

-Latin America & Middle East/Africa: ~6% (Emerging growth from healthcare digitization efforts).​

Market Opportunities & Challenges: Patient Registry Software Market 2026
-Opportunities: A "Real-World Evidence Surge" accelerates adoption through AI-integrated platforms for predictive analytics; cloud-based interoperability with EHR systems enables seamless population health tracking for pharma post-market surveillance. Expansion of patient-powered research networks alongside genomic data management creates de-risked pathways for precision medicine developers targeting rare diseases.

-Challenges: Persistent data privacy regulations like HIPAA/GDPR inflate compliance costs, while siloed legacy systems hinder EHR integration across fragmented hospital networks. Success demands overcoming skilled resource shortages amid rising cybersecurity threats to sensitive registries.

Speak to Our Analyst and Get Customization in the report as per your requirements: https://www.datamintelligence.com/customize/patient-registry-software-market?ram

Market Segmentation Analysis:
-Disease Registry Type
Disease registries lead with 60% share in 2025, essential for tracking chronic conditions and enabling clinical research across Alzheimer's, diabetes, and others.
Cardiovascular registries hold 20%, vital for heart disease monitoring and outcome analysis in high-prevalence cases.​
Cancer registries claim 15%, supporting oncology trials and survival tracking.​
Others (diabetes, orthopedics, Alzheimer's) split 5%, addressing niche epidemiology needs.​

-Functionality Type
Patient care management dominates at 40%, streamlining treatment coordination and outcomes.​
Health Information Exchange (HIE) takes 25%, facilitating secure data sharing across providers.​
Research functionality holds 20%, powering trials and real-world evidence.​
Point of Care (POC) accounts for 15%, aiding real-time clinical decisions.​

-End User
Hospitals lead with 50% share, leveraging registries for population health and compliance.​
Pharmaceutical companies capture 30%, using data for drug development and trials.​
Clinical laboratories hold 20%, supporting diagnostic validation and research.​

-Software Type
Integrated software commands 70%, offering seamless interoperability and scalability.​
Stand-alone versions take 30%, suiting smaller, specialized deployments.​

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription?ram

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

✅ Competitive Landscape
✅ Sustainability Impact Analysis
✅ KOL / Stakeholder Insights
✅ Unmet Needs & Positioning, Pricing & Market Access Snapshots
✅ Market Volatility & Emerging Risks Analysis
✅ Quarterly Industry Report Updated
✅ Live Market & Pricing Trends
✅ Import-Export Data Monitoring

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTW

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.